Tyche Industries Ltd.
Snapshot View

117.45 +2.15 ▲1.9%

27 June 2022, 04:01:00 PM
Volume: 1,216

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.tycheindustries.net
Market Cap 120.54 Cr.
Enterprise Value(EV) 52.88 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 9.10 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 12.92 Trailing Twelve Months Ending 2022-03
Industry PE 29.84 Trailing Twelve Months Ending 2022-03
Book Value / Share 101.68 Trailing Twelve Months Ending 2022-03
Price to Book Value 1.16 Calculated using Price: 117.60
Dividend Yield 1.28 Period Ending 2021-03
No. of Shares Subscribed 1.03 Cr. 10,250,000 Shares
FaceValue 10
Company Profile
Tyche Industries was incorporated in the year 1998 as Siris Soft. Initially, the company was established as a software company but later on was diversified into the manufacture of fine chemicals.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+1.86%
1 Week
-1.34%
1 Month
-10.89%
3 Month
-22.19%
6 Month
-27.99%
1 Year
-45.27%
2 Year
-9.41%
5 Year
+103.20%
10 Year
+761.07%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 16.99 13.43 4.42 5.52 6.59 11.61 12.60 25.55 23.08
Return on Capital Employed (%) 21.85 17.83 7.40 5.22 11.53 17.56 17.36 33.94 30.89
Return on Assets (%) 8.59 6.81 2.80 3.75 4.79 9.18 10.16 20.82 18.88

Balance Sheet View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 39 44 44 46 48 53 60 77 96 104
Non Curr. Liab. 3 4 2 2 3 3 3 3 3 3
Curr. Liab. 46 26 18 20 10 10 11 15 18 13
Minority Int.
Equity & Liab. 88 74 64 67 61 67 74 95 117 120
Non Curr. Assets 29 34 31 31 29 22 21 20 21 19
Curr. Assets 59 40 33 36 32 45 53 75 96 101
Misc. Exp. not W/O
Total Assets 88 74 64 67 61 67 74 95 117 120

Profit Loss View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 78 104 64 54 43 52 54 74 78 62
Other Income 1 0 0 2 2 2 3 4 5 4
Total Income 79 105 64 56 45 53 56 77 83 66
Total Expenditure -68 -94 -57 -51 -37 -43 -45 -52 -54 -51
PBIDT 11 11 7 5 8 11 12 25 29 15
Interest -1 -1 -1 0 0 0 0
Depreciation -1 -1 -3 -2 -2 -2 -2 -2 -2 -2
Taxation -3 -3 -1 0 -3 -3 -3 -6 -7 -3
Exceptional Items -1 0
PAT 6 6 2 2 3 6 7 18 20 10
Adjusted EPS 6 5 2 2 3 6 7 17 20 10

Cash Flow View Details

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 2 3 9 2 12 11 5 4 15 15
Cash Fr. Inv. -2 -6 -6 -1 -1 1 6 1 2 0
Cash Fr. Finan. -3 2 0 -3 2 -11 -1 0 -1 -1
Net Change -2 -1 3 -2 12 1 11 4 17 15
Cash & Cash Eqvt 2 1 3 1 14 15 25 29 46 61

Shareholding Pattern View Details

9 Qtrs 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%)
Promoter 61.97 61.97 61.98 61.98 61.97 61.97 61.97 61.97 61.97
Public 38.03 38.03 38.02 38.02 38.03 38.03 38.03 38.03 38.03
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Wed, 08 Jun 2022
Disclosure Of Related Party Transaction
Disclosure of Related Party Transaction
Tue, 07 Jun 2022
Disclosure On Related Party Transaction
Disclosure on related party transaction
Mon, 30 May 2022
Audited Results For The Quarter And Year Ended 31St March 2022
Audited Results for the Quarter and Year ended 31st March 2022

Technical Scans View Details

Mon, 27 Jun 2022
Opening at High Opening at High
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease 1 Month High Decrease 1 Month
High Decrease 3 Months High Decrease 3 Months
High Decrease 6 Months High Decrease 6 Months

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 200,572.41 835.95 +1.4%
Divi's Laboratories Ltd. 97,518.56 3,679.05 0.0%
Cipla Ltd. 75,086.75 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. 71,855.08 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. 54,559.09 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. 48,438.53 2,858.25 -0.6%
Gland Pharma Ltd. 43,775.42 2,658.60 +0.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 61.29 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 32.99 3,679.05 0.0%
Cipla Ltd. Consolidated 2022-03 29.83 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 32.92 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 51.70 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 62.24 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2022-03 36.13 2,658.60 +0.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 4.18 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8.33 3,679.05 0.0%
Cipla Ltd. Consolidated 2022-03 3.60 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 3.74 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 9.68 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8.12 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2022-03 6.12 2,658.60 +0.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 0.08 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 0.00 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 0.10 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 0.62 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 0.84 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 0.00 2,658.60 +0.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 14.13 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,658.60 +0.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 14.13 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,658.60 +0.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 33,498.14 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 6,969.40 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 19,159.59 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 10,560.00 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 8,004.83 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 3,462.88 2,658.60 +0.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 2,284.68 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 1,984.29 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 2,401.30 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 136.00 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 1,251.88 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 996.96 2,658.60 +0.6%

FAQ's On Tyche Industries Ltd.

Can I Buy Tyche Inds Shares now?

What is the Share Price of Tyche Inds?

What is the Relative Strength Index (RSI) Value of Tyche Inds?

What is the Market Capital (MCAP) of Tyche Inds?

What are the key metrics to analyse Tyche Inds?

What is the Price Performance of Tyche Inds?